For the quarter ending 2025-09-30, KOD had -$32,127K decrease in cash & cash equivalents over the period. -$32,940K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -61,457 | -111,774 |
| Depreciation | 4,587 | 9,197 |
| Stock-based compensation | 14,046 | 31,532 |
| Loss on disposal of long-lived assets | 0 | -8 |
| Non-cash lease impairment expense | 0 | 1,910 |
| Settlement of derivative contracts | 0 | 0 |
| Amortization of operating lease right-of-use asset | 1,952 | 4,069 |
| Prepaid expenses and other current assets | -64 | -108 |
| Other assets | 15 | -68 |
| Accounts payable | 5,315 | 1,129 |
| Accrued and other current liabilities | 5,639 | 3,636 |
| Operating lease liability | -3,011 | -5,133 |
| Long-term deposit | 0 | 1,500 |
| Net cash used in operating activities | -32,880 | -63,750 |
| Purchase of property and equipment | 60 | 403 |
| Deposits on property and equipment | 0 | - |
| Settlement of derivative contracts | 0 | 0 |
| Net cash used in investing activities | -60 | -403 |
| Proceeds from stock option exercises | 813 | 162 |
| Proceeds from issuance of common stock pursuant to espp | 0 | 82 |
| Net cash provided by financing activities | 813 | 244 |
| Net (decrease) in cash, cash equivalents and restricted cash | -32,127 | -63,909 |
| Cash and cash equivalents at beginning of period | 174,258 | - |
| Cash and cash equivalents at end of period | 78,222 | - |
Kodiak Sciences Inc. (KOD)
Kodiak Sciences Inc. (KOD)